Use Able AI chat for product recommendations

Recombinant Pig IL-6 protein (rFc Tag)

Species

Pig

Purity

>90 %, SDS-PAGE

Tag

rFc Tag

Activity

not tested

Cat no : Eg4865



Product Information

Purity >90 %, SDS-PAGE
Endotoxin <0.1 EU/μg protein, LAL method
Activity
Not tested
Expression HEK293-derived Pig IL-6 protein Glu30-Met212 (Accession# P26893) with a rabbit IgG Fc tag at the N-terminus.
GeneID 399500
Accession P26893
PredictedSize 48.2 kDa
SDS-PAGE 48-55 kDa, reducing (R) conditions
Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

Interleukin-6 (IL6) is an interleukin that acts as both a pro-inflammatory and anti-inflammatory cytokine. IL6 protein is secreted by a variety of cell types including T cells and macrophages as phosphorylated and variably glycosylated molecule. IL6 Plays an essential role in the final differentiation of B-cells into Ig-secreting cells involved in lymphocyte and monocyte differentiation. It induces myeloma and plasmacytoma growth and induces nerve cells differentiation Acts on B-cells, T-cells, hepatocytes, hematopoietic progenitor cells and cells of the CNS. IL6 is also considered a myokine, a cytokine produced from muscle, and is elevated in response to muscle contraction. IL6 has been shown to interact with interleukin-6 receptor and glycoprotein 130. Additionally, IL6 is involved in hematopoiesis, bone metabolism, and cancer progression, and has been defined an essential role in directing transition from innate to acquired immunity.

References:

1. Scheller J. et al. (1988). Behring Inst Mitt. Behring Inst Mitt. (83):40-7. 2. Heinrich PC. et al. (2003). Biochem J. 374: 1-20. 3. Rose-John S. et al. (2007). Expert Opin Ther Targets. 11: 613-24. 4. Ming JE. et al. (1989). J Mol Cell Immunol. 4: 203-11. 5. Febbraio MA. et al. (2005). Exerc Sport Sci Rev. 33:114-9. 6. J Appl Physiol. et al. (2005). J Appl Physiol. 98:1154-62.

||
New chat

Able™

正在加载,请稍候...